Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.
Sign Up For Latest News
AI will revolutionize healthcare, from diagnostics to operations, and create new concerns for patient privacy and security.
Five projects received a RAISE Health seed grant to support research and educational initiatives that advance responsible AI in biomedicine.
Five projects received a RAISE Health seed grant to support research and educational initiatives that advance responsible AI in biomedicine.
Robots are becoming a core building block in engineering and healthcare applications, altering the way many industries operate, and improving quality of life for everyone. With AI, robots are further given the ability to learn and adapt so that they can work collaboratively alongside humans and other robots in real-world environments. This industry brief provides a cross-section of key research – at HAI and across Stanford – that leverages AI methods into new algorithms for human robot interaction and robot navigation. Discover how researchers are designing intelligent robots that learn and adapt to human demonstration, and how they could be used to disrupt and create markets in a wide range of industries including manufacturing, healthcare, autonomous vehicles, and many more.
Robots are becoming a core building block in engineering and healthcare applications, altering the way many industries operate, and improving quality of life for everyone. With AI, robots are further given the ability to learn and adapt so that they can work collaboratively alongside humans and other robots in real-world environments. This industry brief provides a cross-section of key research – at HAI and across Stanford – that leverages AI methods into new algorithms for human robot interaction and robot navigation. Discover how researchers are designing intelligent robots that learn and adapt to human demonstration, and how they could be used to disrupt and create markets in a wide range of industries including manufacturing, healthcare, autonomous vehicles, and many more.
Current societal trends reflect an increased mistrust in science and a lowered civic engagement that threaten to impair research that is foundational for ensuring public health and advancing health equity. One effective countermeasure to these trends lies in community-facing citizen science applications to increase public participation in scientific research, making this field an important target for artificial intelligence (AI) exploration. We highlight potentially promising citizen science AI applications that extend beyond individual use to the community level, including conversational large language models, text-to-image generative AI tools, descriptive analytics for analyzing integrated macro- and micro-level data, and predictive analytics. The novel adaptations of AI technologies for community-engaged participatory research also bring an array of potential risks. We highlight possible negative externalities and mitigations for some of the potential ethical and societal challenges in this field.
Current societal trends reflect an increased mistrust in science and a lowered civic engagement that threaten to impair research that is foundational for ensuring public health and advancing health equity. One effective countermeasure to these trends lies in community-facing citizen science applications to increase public participation in scientific research, making this field an important target for artificial intelligence (AI) exploration. We highlight potentially promising citizen science AI applications that extend beyond individual use to the community level, including conversational large language models, text-to-image generative AI tools, descriptive analytics for analyzing integrated macro- and micro-level data, and predictive analytics. The novel adaptations of AI technologies for community-engaged participatory research also bring an array of potential risks. We highlight possible negative externalities and mitigations for some of the potential ethical and societal challenges in this field.
The Hoffman-Yee Research Grants are designed to address significant scientific, technical, or societal challenges requiring an interdisciplinary team and a bold approach.
The Hoffman-Yee Research Grants are designed to address significant scientific, technical, or societal challenges requiring an interdisciplinary team and a bold approach.
This brief explores the complexities of accounting for race in clinical algorithms for evaluating kidney disease and the implications for tackling deep-seated health inequities.
This brief explores the complexities of accounting for race in clinical algorithms for evaluating kidney disease and the implications for tackling deep-seated health inequities.
Medical and AI experts build a benchmark for evaluation of LLMs grounded in real-world healthcare needs.
Medical and AI experts build a benchmark for evaluation of LLMs grounded in real-world healthcare needs.
This industry brief focuses on AI research in healthcare and life sciences, with particular attention to its implications in a post COVID-19 world. Stanford HAI synthesize the latest from Stanford faculty across drug discovery, telehealth, ambient intelligence, operational excellence, medical imaging, augmented intelligence, and data and privacy. Read to learn more about how the adoption of AI may transform these applications.
This industry brief focuses on AI research in healthcare and life sciences, with particular attention to its implications in a post COVID-19 world. Stanford HAI synthesize the latest from Stanford faculty across drug discovery, telehealth, ambient intelligence, operational excellence, medical imaging, augmented intelligence, and data and privacy. Read to learn more about how the adoption of AI may transform these applications.
Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c < 7%), early technology use (continuous glucose monitoring starts <1 month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study 1). Primary outcome was HbA1c change from 4 to 12 months after diagnosis; the secondary outcome was achieving the HbA1c targets. The 4T Study 1 cohort (36.8% Hispanic and 35.3% publicly insured) had a mean HbA1c of 6.58%, 64% with HbA1c < 7% and mean time in the range (70-180 mg dl-1) of 68% at 1 year after diagnosis. Clinical implementation of the 4T Study 1 met the prespecified primary outcome and improved glycemia without unexpected serious adverse events. The strategies in the 4T Study 1 can be used to implement systematic and equitable care for individuals with T1D and translate to care for other chronic diseases.
Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c < 7%), early technology use (continuous glucose monitoring starts <1 month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study 1). Primary outcome was HbA1c change from 4 to 12 months after diagnosis; the secondary outcome was achieving the HbA1c targets. The 4T Study 1 cohort (36.8% Hispanic and 35.3% publicly insured) had a mean HbA1c of 6.58%, 64% with HbA1c < 7% and mean time in the range (70-180 mg dl-1) of 68% at 1 year after diagnosis. Clinical implementation of the 4T Study 1 met the prespecified primary outcome and improved glycemia without unexpected serious adverse events. The strategies in the 4T Study 1 can be used to implement systematic and equitable care for individuals with T1D and translate to care for other chronic diseases.
Advances in artificial intelligence technology offer unprecedented opportunities to improve health and medicine, from accelerating biomedical research to strengthening care delivery and patient outcomes.
Advances in artificial intelligence technology offer unprecedented opportunities to improve health and medicine, from accelerating biomedical research to strengthening care delivery and patient outcomes.
HAI Associate Director Curt Langlotz explains the current state of health regulation and where we need to move to protect patients and better assist doctors.
HAI Associate Director Curt Langlotz explains the current state of health regulation and where we need to move to protect patients and better assist doctors.